Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$203K Buy
+562
New +$192K 0.09% 179
2025
Q2
Sell
-853
Closed -$266K 177
2025
Q1
$266K Sell
853
-516
-38% -$152K 0.15% 132
2024
Q4
$357K Sell
1,369
-132
-9% -$39.2K 0.2% 106
2024
Q3
$484K Buy
1,501
+449
+43% +$147K 0.29% 75
2024
Q2
$329K Sell
1,052
-1
-0.1% -$294 0.22% 92
2024
Q1
$299K Buy
1,053
+78
+8% +$22.8K 0.23% 88
2023
Q4
$281K Buy
975
+25
+3% +$6.81K 0.23% 83
2023
Q3
$255K Hold
950
0.23% 85
2023
Q2
$211K Buy
950
+100
+12% +$23.2K 0.19% 101
2023
Q1
$205K Buy
+850
New +$209K 0.21% 91

Other funds holding AMGN

Core Wealth Partners's AMGN Position: Q2 2026 in Review

Core Wealth Partners opened a new position in Amgen (AMGN) in Q2 2026: 562 shares worth $203K. The stake represents 0.09% of the portfolio and ranks #179 among its holdings. This is a return to the name: Core Wealth Partners previously reported a position in AMGN as recently as Q1 2025.

Core Wealth Partners first reported a position in AMGN in Q1 2023 and has held it in 10 quarters since. The position peaked at $484K in Q3 2024. 1,055 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Core Wealth Partners held 562 shares of Amgen worth $203K as of Q2 2026.
  • Amgen was a new Core Wealth Partners position in Q2 2026.
  • Amgen made up 0.09% of Core Wealth Partners's portfolio in Q2 2026, its #179 holding.
  • Core Wealth Partners first reported a position in Amgen in Q1 2023 and has held it in 10 quarters since.
  • Core Wealth Partners's Amgen position peaked at $484K in Q3 2024.
  • 1,055 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Core Wealth Partners's 13F filing for Q2 2026, filed 17 Jul 2026.